Aurea completed the investment in Nutraceutical Research Innovations.

Aurea, a private equity firm, completed the investment in Nutraceutical Research Innovations, a provider of nutraceutical and cosmeceutical products. Financial terms were not disclosed. "Zenagen and ACT/IV are outstanding brands that deliver proven, effective solutions for their customers. With increasing consumer demand for premium, purpose-driven haircare products, NRI is exceptionally well-positioned to thrive. We look forward to bringing Auréa’s operational experience and unparalleled network in working with the team to unlock the brands’ next phase of growth," Paul Raphael, Aurea Founding Partner.